A Critical Review of Upcoming New Therapeutic Options in Paediatric Endocrinology

Abstract

Novel and innovative therapeutic options are now available or will soon become available for treating children and adolescents with endocrine disorders and diabetes. Some of these new medicines and procedures have already been proven effective and safe in adults at least in the short term but their use in children is still limited and some efficacy and safety related aspects raise caution especially in the long term. The purpose of this issue is to provide an overview of some of the medicines upcoming to the market, highlighting the advantages and the still existing grey zones.